In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?

In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?

Abstract Background The study aimed to compare the diagnostic performance of T2-weighted imaging (T2WI) score 3 transition zone (TZ) lesions between Prostate Imaging and Reporting Data System (PI-RADS) v2.1 and modified PI-RADS v2.1-B. Results Among TZ lesions (n = 78), 47 (60.0%) had T2WI score of...

Full description

Bibliographic Details
Main Authors:	Jihae An, Young Joong Kim, Jae Young Seo, Cheol Mog Hwang, Dong Hyun Oh, Mu-Sik Lee, Keum Won Kim
Format:	Article
Language:	English
Published:	SpringerOpen 2021-08-01
Series:	The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:	Multiparametric magnetic resonance imaging Prostate cancer Prostate Imaging and Reporting Data System
Online Access:	https://doi.org/10.1186/s43055-021-00543-9

Similar Items

The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
by: Dong-Soo Kim, et al.
Published: (2021-04-01)

Prevalence of prostate cancer in MRI-TRUS fusion biopsy patients with suspected lesion in Multi-Parametric MRI with PI-RADS 2 and 3 who have previously undergone prostate biopsy
by: Katebi K, et al.
Published: (2022-06-01)

Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
by: Chung-Un Lee, et al.
Published: (2022-08-01)

The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)
by: Jiazhou Liu, et al.
Published: (2022-09-01)

Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study
by: Yongheng Zhou, et al.
Published: (2023-01-01)

Magnetic resonance semiotics of prostate cancer according to the PI-RADS classification. The clinical diagnostic algorithm of a study
by: A. S. Korobkin, et al.
Published: (2016-03-01)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
by: Shuanbao Yu, et al.
Published: (2020-11-01)

Prostate Imaging Reporting and Data System (PI-RADS) v 2.1: Overview and Critical Points
by: Chan Kyo Kim
Published: (2023-01-01)

A multicentre parallel-group randomised trial assessing multiparametric MRI characterisation and image-guided biopsy of prostate in men suspected of having prostate cancer: MULTIPROS study protocol
by: Magdalena Szewczyk-Bieda, et al.
Published: (2019-11-01)

Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study
by: Guan-Hui Cai, et al.
Published: (2021-05-01)

Study of iron metabolism based on T2* mapping sequences in PI-RADS 3 prostate lesions
by: Wenhao D, et al.
Published: (2023-05-01)

Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre Study
by: Dominic James Gavin, et al.
Published: (2020-07-01)

Impact of PI-RADS v2 on indication of prostate biopsy
by: George de Queiroz Rozas, et al.

Predictors of prostate cancer cetection in MRI PI-RADS 3 lesions – Reality of a terciary center
by: Débora Araújo, et al.
Published: (2023-12-01)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
by: Paulius Aliukonis, et al.
Published: (2017-04-01)

Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging
by: Ricardo deAlmeida S Jr, et al.
Published: (2023-09-01)

A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies
by: Edoardo Beatrici, et al.
Published: (2024-03-01)

Fusion prostate biopsy: tips and tricks to improve rigid registration
by: Angelo Naselli, et al.
Published: (2022-05-01)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
by: Sangeet Ghai, et al.
Published: (2015-01-01)

Interreader agreement in different PI-RADS systems in multiparametric prostate magnetic resonance imaging: A head-to-head comparison between PI-RADSv2 and v2.1
by: Merve Horoz, et al.
Published: (2021-01-01)

Pearls and Pitfalls in Applying PI-RADS 2.1
by: Ankur Pandey, et al.

PI‐RADS 3 score: A retrospective experience of clinically significant prostate cancer detection
by: Andrés Camacho, et al.
Published: (2023-07-01)

Detection of anterior prostate cancer using a magnetic resonance imaging-transrectal ultrasound fusion biopsy in cases with initial biopsy and history of systematic biopsies
by: Masakazu Abe, et al.
Published: (2023-12-01)

The Prostate Health Index and multi-parametric MRI improve diagnostic accuracy of detecting prostate cancer in Asian populations
by: Changhee Ye, et al.
Published: (2022-11-01)

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
by: Changming Wang, et al.
Published: (2022-11-01)

Development and validation of a novel nomogram predicting clinically significant prostate cancer in biopsy‐naive men based on multi‐institutional analysis
by: Qingyu Ge, et al.
Published: (2023-12-01)

Is transrectal ultrasound-guided systematic biopsy necessary after PI-RADS 4 is targeted?
by: Hyun Soo Kim, et al.
Published: (2021-09-01)

Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece
by: Mario Lourenço, et al.
Published: (2020-01-01)

Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
by: Caterina Gaudiano, et al.
Published: (2023-02-01)

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
by: M Klingebiel, et al.
Published: (2022-12-01)

Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
by: Rui Su, et al.
Published: (2022-07-01)

Magnetic resonance imaging–ultrasound fusion-targeted biopsy combined with systematic 12-core ultrasound-guided biopsy improves the detection of clinically significant prostate cancer: Are we ready to abandon the systematic approach?
by: Christopher Antonio Febres-Aldana, et al.
Published: (2020-01-01)

Utilization of Multiparametric MRI of Prostate in Patients under Consideration for or Already in Active Surveillance: Correlation with Imaging Guided Target Biopsy
by: Jinxing Yu, et al.
Published: (2020-06-01)

Clinical Application of the New Prostate Imaging for Recurrence Reporting (PI-RR) Score Proposed to Evaluate the Local Recurrence of Prostate Cancer after Radical Prostatectomy
by: Federica Ciccarese, et al.
Published: (2022-09-01)

Diagnostic Value of Cognitive-Registration Multiparametric Magnetic Resonance Guided Biopsy for the Detection of Prostate Cancer after Initial Negative Biopsy
by: Igor Tomašković, et al.
Published: (2018-01-01)

Attitudes and perceptions towards multiparametric magnetic resonance imaging of the prostate: A national survey among Italian urologists
by: Arnaldo Stanzione, et al.
Published: (2020-12-01)

Less qualitative multiparametric magnetic resonance imaging in prostate cancer can underestimate extraprostatic extension in higher grade tumors
by: Stephen Schmit, et al.
Published: (2024-04-01)

Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena
by: Amanda Khoo, et al.
Published: (2022-05-01)

Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
by: Michael E. Rezaee, et al.
Published: (2020-09-01)

Focal therapy for localized prostate cancer: is there a “middle ground” between active surveillance and definitive treatment?
by: Cihan H Demirel, et al.
Published: (2019-01-01)